SCHEMBL8564525

SCHEMBL8564525

CCOC(=O)CN1CCC(N2C(=O)Nc3ccccc3C2c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
GAA P10253 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
CASP3 P42574 1/20 0.41
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
ATM Q13315 1/20 0.39
TACR1 P25103 1/20 0.39
CNR1 P21554 1/20 0.39
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8597954 0.99 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19GAASMN1; SMN2
SCHEMBL8565908 0.86 TACR1 (0.41) CYP1A2CYP2C9CYP2C19GAAMEN1
SCHEMBL8570205 0.84 MEN1 (0.41) GAAMEN1KMT2AALDH1A1TACR1
SCHEMBL8564971 0.84 TACR1 (0.43) MEN1KMT2AALDH1A1TACR1
SCHEMBL8567952 0.80 SLC18A3 (0.49) TACR1
SCHEMBL6168606 0.80 OPRL1 (0.52) CYP2C9CYP2C19MEN1KMT2A
SCHEMBL29445321 0.80 OPRL1 (0.52) CYP2C9CYP2C19MEN1KMT2A
SCHEMBL8568996 0.79 KDM1A (0.49) SMN1; SMN2MEN1KMT2ACHRM1LMNA
SCHEMBL6168284 0.79 TACR1 (0.41) SMN1; SMN2MEN1KMT2AATMTACR1
SCHEMBL6168102 0.79 CHRM3 (0.42) TACR1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed